Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 2/20 | 0.41 |
| ▸ | MMP13 | P45452 | 4/20 | 0.39 |
| ▸ | ADAM17 | P78536 | 4/20 | 0.39 |
| ▸ | MMP1 | P03956 | 4/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.38 |
| ▸ | RORC | P51449 | 2/20 | 0.37 |
| ▸ | MMP9 | P14780 | 1/20 | 0.37 |
| ▸ | KCNQ1 | P51787 | 1/20 | 0.37 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.37 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21035393 | 1.00 | ACACB (0.41) | ACACBMMP13ADAM17MMP1GAA | |
| SCHEMBL21035341 | 0.92 | ACACB (0.42) | ACACBMMP13ADAM17MMP1GAA | |
| SCHEMBL21035662 | 0.90 | ACACB (0.41) | ACACBMMP13ADAM17MMP1EPHX2 | |
| SCHEMBL21035580 | 0.90 | ACACB (0.41) | ACACBMMP13ADAM17MMP1EPHX2 | |
| SCHEMBL21035127 | 0.90 | ACACB (0.41) | ACACBMMP13ADAM17MMP1EPHX2 | |
| SCHEMBL21035541 | 0.86 | GHSR (0.41) | ADAM17MMP1EPHX2KCNQ1HCRTR1 | |
| SCHEMBL21035418 | 0.86 | GHSR (0.41) | ADAM17MMP1EPHX2KCNQ1HCRTR1 | |
| SCHEMBL21035391 | 0.86 | GHSR (0.41) | ADAM17MMP1EPHX2KCNQ1HCRTR1 | |
| SCHEMBL21034927 | 0.86 | ACACB (0.42) | ACACBMMP13ADAM17MMP1GAA | |
| SCHEMBL21035086 | 0.86 | ACACB (0.42) | ACACBMMP13ADAM17MMP1MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019104011-A1 | CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE | BIOMARIN PHARMACEUTICAL INC. (US) | 2019-05-31 | — | — | WO | disclosed |